Loading…
Lobbying Spend
—
Filings
10
Firms Hired
1
Active Period
2011–2013
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Safeguarding America's Pharmaceuticals Act of 2013
2013 · fourth_quarter · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957
Client expense: — · Firm income: —
Matched citations: HR 1919
Drug Supply Chain Security Act
2013 · fourth_quarter · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957
Client expense: — · Firm income: —
Matched citations: S. 957
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957
Client expense: — · Firm income: $50,000
Matched citations: HR 1919
Drug Supply Chain Security Act
2013 · third_quarter · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957
Client expense: — · Firm income: $50,000
Matched citations: S. 957
Safeguarding America's Pharmaceuticals Act of 2013
2013 · second_quarter · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957
Client expense: — · Firm income: $50,000
Matched citations: HR 1919
Drug Supply Chain Security Act
2013 · second_quarter · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Issues affecting resellers of pharmaceutical products in HR 1919 and S. 957
Client expense: — · Firm income: $50,000
Matched citations: S. 957
Source: Senate LDA